Loading...
•
Dec 31, 2022
Bausch Health Q4 2022 Earnings Report
Announced fourth-quarter and full-year 2022 results, with Q4 revenues of $2.2 billion, flat reported, up 4% organic.
Key Takeaways
Bausch Health reported flat revenue of $2.2 billion for the fourth quarter of 2022 compared to the fourth quarter of 2021, but saw a 4% increase organically. For the full year, revenues were $8.1 billion, a 4% decrease reported, but a 2% increase organically. The company reduced debt by $464 million in the fourth quarter and provided 2023 guidance for Bausch Health (excl. B+L).
Fourth-Quarter revenues of $2.2 billion, flat reported, up 4% organic
Full-Year revenues of $8.1 billion, down 4% reported, up 2% organic
Unrestricted B+L from BHC covenants
Reduced debt by $464 million in the fourth quarter
Revenue by Segment
Forward Guidance
Bausch Health (excl. B+L) has provided guidance for the full year of 2023 as follows: •Full-year revenue range of $4.45 - $4.6 billion •Full-year adjusted EBITDA (non-GAAP)1 range of $2.3 - $2.4 billion
Positive Outlook
- Full-year revenue range of $4.45 - $4.6 billion
- Full-year adjusted EBITDA (non-GAAP) range of $2.3 - $2.4 billion
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...